Pharmacy and Pharmaceutical Conference

Epigenetic Therapies in Cancer

Targeting the reversible changes to DNA and histones that control gene expression without changing the underlying genetic coding, epigenetic treatments promise a promising new avenue in the cancer diagnosis. Through the reversal of abnormal epigenetic modifications including DNA methylation and histone acetylation, these medicines seek to restore normal gene function in cancer cells. Medication such as histone deacetylase inhibitors and DNA methyltransferase inhibitors suppresses oncogenes or reactivates tumor suppressor genes, changing the behavior of cancer cells and enhancing therapy results. These treatments present the possibility of more accurate and successful interventions as our knowledge of epigenetic pathways grows, improving the capacity to target and treat a variety of tumors with fewer adverse effects.

• DNA Methylation Inhibitors
• Epigenetic Biomarkers for Cancer
• Combination Therapies with Epigenetic Agents